| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |